Dr. Kathleen K. Harnden
Claim this profileInova Schar Cancer Institute
Area of expertise
Breast Cancer
Kathleen K. Harnden has run 5 trials for Breast Cancer. Some of their research focus areas include:
Diarrhea
Kathleen K. Harnden has run 1 trial for Diarrhea. Some of their research focus areas include:
Affiliated Hospitals
Inova Schar Cancer Institute
INOVA Fair Oaks Hospital
Clinical Trials Kathleen K. Harnden is currently running
Elacestrant Combinations
for Breast Cancer
This is a multicenter, Phase 1b/2 trial in participants with estrogen receptor positive/human epidermal growth factor receptor 2 negative (ER+/HER2-) advanced/metastatic breast cancer. The phase 1b part of the trial will determine the recommended Phase 2 dose (RP2D) of elacestrant when administered in combination with alpelisib, everolimus, palbociclib, capivasertib, and ribociclib. The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations.
Recruiting
1 award
Phase 1 & 2
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting
2 awards
Phase 3
6 criteria
More about Kathleen K. Harnden
Clinical Trial Related
2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Kathleen K. Harnden has experience with
- Alpelisib
- Everolimus
- Trastuzumab
- Pertuzumab
- Abemaciclib
- Crofelemer
Breakdown of trials Kathleen K. Harnden has run
Breast Cancer
Prevention of Diarrhea
Symptomatic Relief of Diarrhea
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kathleen K. Harnden specialize in?
Kathleen K. Harnden focuses on Breast Cancer and Diarrhea. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Kathleen K. Harnden currently recruiting for clinical trials?
Yes, Kathleen K. Harnden is currently recruiting for 2 clinical trials in Fairfax Virginia. If you're interested in participating, you should apply.
Are there any treatments that Kathleen K. Harnden has studied deeply?
Yes, Kathleen K. Harnden has studied treatments such as Alpelisib, Everolimus, Trastuzumab.
What is the best way to schedule an appointment with Kathleen K. Harnden?
Apply for one of the trials that Kathleen K. Harnden is conducting.
What is the office address of Kathleen K. Harnden?
The office of Kathleen K. Harnden is located at: Inova Schar Cancer Institute, Fairfax, Virginia 22031 United States. This is the address for their practice at the Inova Schar Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.